Background. Renal transplantation has been regarded as the treatment of choice for end-stage renal disease. Renal transplantation increases the risk of cancers due to longterm immunosuppression. The types of post-transplantation malignancies may vary among different geographic regions and ethnic populations. To date, large population-based studies of post-transplantation malignancies in Asian renal transplant recipients (RTRs) have rarely been reported. Methods. To investigate the patterns of post-transplantation malignancies in Chinese RTRs, we performed a nationwide population-based cohort study between 1997 and 2008 based on data from the National Health Insurance Database in Taiwan. Patterns of cancer incidence in RTRs were compared with those of the general population using standardized incidence ratios (SIRs). Results. Among the 4716 RTRs (2475 males and 2241 females; mean age 44.1 6 12.4 years) and 22 556 person-years of observation, 320 post-transplant cancers were diagnosed. The SIR of all cancers was 3.75 (95% confidence interval 3.36-4.18). Women had a higher risk than men for the development of malignancies (SIR 5.04 for women and SIR 2.88 for men). Renal, bladder and liver cancers were the most common cancers, with SIRs of 44.29, 42.89 and 5.07, respectively. When stratified by age, RTRs of young age at transplant (<20 years) had the highest risk of post-transplantation malignancies. Conclusions. This study demonstrates different patterns of malignancies after renal transplantation in Chinese RTRs, with higher incidences of kidney and bladder cancers. Physicians should be more vigilant in examining RTRs for posttransplantation malignancies especially in younger patients.
Introduction
Renal transplantation is considered the treatment of choice in end-stage renal disease and renal transplant recipients (RTRs) are known to have a higher cancer incidence compared with the general population [1] [2] [3] . Post-transplantation malignancies, which have shown increased frequency during the past decades [4] , remain one of the major causes of mortality among RTRs and are anticipated to be the leading cause of death within the next 20 years [5] . The types of post-transplantation malignancies may vary among different geographic regions and ethnic populations. Non-melanoma skin cancer (NMSC) is the most common malignancy following renal transplantation in Western populations [1, 3, 4, 6, 7] . Gastric and kidney cancers are the most common posttransplantation malignancies in Japan [8] . Recently, several studies have demonstrated a markedly increased incidence of transitional cell carcinoma (TCC) in Chinese RTRs [9] [10] [11] , suggesting a different pattern of cancer development in Asia. These studies were either limited to a single regional center or to small case numbers [8] [9] [10] [11] . A large population-based study is therefore needed to quantify the risk of post-transplantation malignancies in Asian RTRs. The aim of our nationwide survey in Taiwan was to investigate the prevalent cancer types in a population-based design and calculate standardized incidence ratios (SIRs) of all cancers following renal transplantation.
Materials and methods

Data source
In this study, we analyzed the published national data from the National Health Insurance Research Database (NHIRD) in Taiwan. Taiwan initiated a single-payer National Health Insurance (NHI) Program in 1995. As of the end of 2008, 22 918 144 persons were enrolled in the NHI Program, constituting 99.44% of the entire population of Taiwan. Most medical institutions (93%) have been contracted to the Bureau of NHI. The completeness and accuracy of the NHI claims databases were audited by the Department of Health and the Bureau of NHI. NHIRD includes all claims from ambulatory care and inpatient care and provides scrambled patient identification number, birth date, sex, dates of clinical visits, diagnostic codes in the format of the International Classification of Disease, Revision 9, Clinical Modification (ICD-9-CM), details of inpatient and ambulatory care orders and the date and reason of withdrawal from this program. Personal information including family history, lifestyle and habits such as smoking and alcohol use was not available from the NHIRD. The NHIRD has been the source of many epidemiological studies published in peer-reviewed journals [12, 13] .
In Taiwan, the insured who suffer from certain major diseases can apply for a catastrophic illness certificate, which grants exemption from co-payment. Solid organ transplant and malignancies are both statutorily included in the category of catastrophic illnesses. Application of a catastrophic illness certificate for cancer requires cytological or pathological evidence supporting the diagnosis of cancer, and the diagnosis of RTR is given by board-certified nephrologists or transplant surgeons.
The catastrophic illness dataset contains scrambled patient identification number, patient birthday, gender, diagnostic codes in the format of the ICD-9-CM and date of diagnosis. Therefore, the NHIRD, one of the largest and most comprehensive nationwide population-based databases in the world, offers an opportunity to estimate the risk of malignancies among Asian RTRs.
Study sample
We identified renal transplant patients (ICD-9-CM code V420, 996.81) in the catastrophic illness database between 1 January 1997 and 31 December 2008. The RTRs who received transplantation before 1 January 1997 were not included in the present study. All enrolled recipients were followed up from the date of renal transplantation to the date of a first-time diagnosis of cancer, death, the end of follow-up in the medical records or the end of 2008. Cases of malignancies were also identified in the same catastrophic illness database using the ICD-9-CM code of 140-208.91. We excluded patients diagnosed with malignancies before or within 3 months after renal transplantation to minimize the influence of increased medical examinations when being assessed for transplantation. We did not include patients with in situ malignancies because such malignancies are not included in the category of catastrophic illnesses. RTRs diagnosed with Kaposi sarcoma were also excluded due to the lack of national incidence rate for Kaposi sarcoma. Since the dataset used in the study consisted of de-identified secondary data released to the public for research purposes, this study was exempt from full review by the Institutional Review Board.
In Taiwan, 24.6% of RTRs received living-related transplants and 75.4% of them received cadaveric transplants [http://www.transplant .org.tw/big5/upload3/index.asp?page¼2&;lastpage¼10&searchword¼ (6 March 2011, date last accessed]. A thorough pre-transplant screening is conducted for occult malignancy, including chest X-ray, breast and abdominal sonography, urinalysis, fecal occult blood testing, screening for nasopharyngeal carcinoma, Pap smear, serum alpha-fetoprotein (AFP) and prostate-specific antigen (PSA) level. Patients with chronic hepatitis B or C should receive antiviral therapy and achieve sustained viral response before renal transplantation. After transplantation, urinalyses are performed every 3 months. If microscopic or gross hematuria is present in the urine, cystoscopy, ureteroscopy and retrograde urography are done to exclude malignancy. For patients with hepatitis B or C virus infection, serum AFP and liver sonography are checked every 3 months [14] . Also, annual breast sonography and gynecologic examination for female RTRs and testing for serum PSA level for male ones are arranged.
The induction immunosuppression of renal transplantation in Taiwan is usually achieved by methylprednisolone pulse therapy, with or without anti-CD25 therapy (daclizumab or basiliximab) [15] . The maintenance immunosuppressive regimen generally consisted of triple therapy, including corticosteroid, calcineurin inhibitor (cyclosporine or tacrolimus) and anti-metabolite (azathioprine or mycophenolate mofetil) [15, 16] . Sirolimus usually substitutes for calcineurin inhibitors or anti-metabolite if intolerable adverse effects develop [17] .
Statistical analysis
We examined the associations among RTRs and specific cancer types using SIRs.
SIR was calculated as the number of observed cancer cases among RTRs divided by the expected number of cancer cases. The expected number of cancer cases was obtained from the product of national age-specific, gender-specific incidence rates obtained from the Taiwan National Cancer Registry [18] and the number of person-years at risk. The period of risk was calculated from the date of transplantation to the date of a first-time diagnosis of cancer, death, the end of follow-up in the medical records or the end of 2008.
To assess the age effect on the relative risk of malignancies, we divided all enrollees into four age categories: <20 years, 20-39 years, 40-59 years and >60 years at renal transplantation. We analyzed whether the association of post-transplantation malignancies varied with the duration after renal transplantation. Patients were classified into four groups based on the duration of follow-up: <1 year, 1-5 years, 5-10 years and >10 years. A 95% confidence interval (CI) was calculated for each SIR assuming a Poisson distribution for the observed number of cases. A two-tailed P-value of <0.05 was regarded as statistically significant.
Results
Study cohort
The total cohort consisted of 4716 RTRs (2475 men and 2241 women) with a mean age AE SD at transplant of 44.1 AE 12.4 years ( Table 1 ). The mean length AE SD of followup was 4.8 AE 3.1 years with 22 556 person-years of follow-up. The most frequent length of follow-up was between 1 and 5 years, with 8.6% of patients followed up for >10 years. 
Cancer prevalence
During the study period, a total of 320 cancers were identified. The overall prevalence of malignancies was 1.4 per 100 person-years. Malignancies of urinary tract were the most common, representing 51.9% of the cancers diagnosed ( Table 2 ). The next most common cancers were liver, colorectal and breast cancers, constituting 18.8, 4.7 and 4.1% of the cancers, respectively. Stratified SIR analysis by age and duration of follow-up
SIRs of all cancers in RTRs
We analyzed SIRs of all cancers, kidney, bladder and liver cancers, with stratification by age and duration of follow-up ( Table 5 ). RTRs carried an elevated risk of cancers in every age group. The risk of all cancers in patients <20 years was the highest (SIR 40.00, 95% CI 15.32-104.47). The risk progressively decreased with age (SIR 8.20 for 20-39 years, SIR 4.14 for 40-59 years and SIR 2.31 for >60 years).
The risk was extraordinarily high in the first year after renal transplantation (SIRs 27.50 for men and 47.70 for women). The risk of cancer declined as follow-up duration increased (SIR 7.09 for 1-5 years, SIR 1.43 for 5-10 years and SIR 0.18 for >10 years).
Discussion
In the present study, we found that the overall prevalence of post-transplantation malignancy was 1.4 per 100 personyears, similar to the findings of several large studies [19, 20] . The SIR for total cancers was 3.75 (95% CI 3.36-4.18), indicating greater incidence of cancers in RTRs than in the general population. Women had a higher risk than men for the development of malignancies (SIRs 5.04 for women and 2.88 for men). The differences in SIRs between female and male RTRs was mainly attributable to more female cases of kidney and bladder cancers, which outnumbered male cases two to one. In our study, the SIR in men (SIR 2.88, 95% CI 2.44-3.40) was lower than that reported in populations from Australia (SIR 3.45, 95% CI 3.20-3.70) [21] and Nordic countries (SIR 4.6, 95% CI 4.0-5.2) [19] .
The distribution of cancer sites in our study differed from that in Western countries, consistent with the findings of previous studies [9, 10] . The prevalence of each cancer type in our series was also different from that in the general Taiwanese population. The most common cancers in Taiwan are colorectal, liver and lung cancers, followed by breast cancer [18], whereas there were higher prevalences of urological and liver cancers among the RTRs in this study. Many studies have shown that RTRs are at greater risk of developing skin cancers, especially squamous cell carcinoma and basal cell carcinoma [22] . In a Nordic RTR group, the risk of developing skin cancer was 30 times higher than that expected in the general population [2] . However, the risk of skin cancers in Asian RTRs was less than that in Western countries. In our study, the risk of NMSC was elevated only in female RTRs (SIR ¼ 4.67), whereas the risk of melanoma was elevated only in male RTRs (SIR ¼ 9.45). A systemic dermatological surveillance program of NMSC is recommended in female RTRs, and a more vigorous surveillance program for melanoma is suggested in male RTRs. Because in situ cancers are not included in the category of catastrophic illnesses, we could not exclude the possibility of underestimation of NMSC. Nonetheless, previous studies in Taiwan [9, 10] and Japan [23] have suggested that low incidence of skin cancer is a characteristic of Asian RTRs, similar to the findings in our study. It may be attributed to genetic variation in the development of skin cancer and the low background cancer incidence rates in Asians.
The risks of kidney and bladder cancers were significantly higher after renal transplantation (SIR 44.29 for kidney cancer, SIR 42.89 for bladder cancer). From the results of previous studies, there is higher risk of TCC in RTRs in Taiwan (cumulative incidence rate 4.21%) [10] . Agraharkar et al. [24] also reported that the risk of kidney cancer is 7-fold higher than that in the general population in North American RTRs. Multiple factors including immunosuppressive status, underlying renal diseases, genetic background and environmental factors might contribute to the development of urinary tract cancers. Studies in Taiwan reported a high incidence of TCC among uremic patients undergoing maintenance dialysis [25, 26] . Another study of hemodialysis patients in northern Taiwan showed SIRs for kidney and bladder cancers of 24.1 and 16.4, respectively [27] . Vajdic et al. [3] reported that cancer incidence was slightly increased during dialysis (SIR ¼ 1.35, 95% CI: 1.27-1.45). The above reports imply that uremia is an important promoting factor for urinary tract cancers. Two endemic risk factors, the use of Chinese herbs containing aristolochic acid and chronic arsenic poisoning from underground water intake, may contribute to a high incidence of urinary tract cancers in RTRs [9] . In our study, the SIRs of kidney and bladder cancers in female RTRs were significantly higher than those in men. This might be due to a higher percentage of compound analgesic use or Chinese herb use among female Chinese RTRs [9, 11] . In summary, physicians should be more vigilant in checking for urinary tract cancers in RTRs, especially in female patients.
There is ongoing controversy over the mechanisms of oncogenesis in RTRs. One hypothesis is that cancers result from oncogenic viral infection and another is reduced immune surveillance against a variety of nonviral tumor antigens [28] . Taiwan is within the epidemic area of hepatitis B virus (HBV) in Far East Asia, and the prevalence rate of hepatitis B antigenemia in RTRs has been estimated to be 9 to 24% [29, 30] . HBV is an important risk factor in the pathogenesis of liver cancer. The increased risk of liver cancer in our study supported the hypothesis that cancers result from oncogenic viral infection.
Previous studies comparing the cancer risk between younger and elder RTRs showed that elder RTRs had a greater risk for the development of post-transplantation malignancies than younger ones [6] . However, few studies reported the risk of post-transplantation malignancies in different age categories compared with the age-matched general population. Our data demonstrated that the youngest RTRs (<20 years at the time of transplantation) had the highest risk of all cancers, with SIR of 40.00 (95% CI 15.32-104.47). This finding was consistent with the pattern observed in previous studies [7, 8, 20, 24, 31] . In this population, extraordinarily high risks of bladder cancer (SIR 3105.22, 95% CI 437.37-22 043.41) and kidney cancer (SIR 779.37, 95% CI 194.81-3115.08) were observed. This was probably due to smaller incidence rates among a normal younger population, whereas the larger background cancer incidence rate in normal elderly population dampened the difference between elderly RTRs and normal elderly population. It is important to emphasize this issue because cancer in younger recipients may result in a greater impact on life expectancy than in elderly recipients and raises the question of whether this group of patients requires a more intensive post-transplantation cancer surveillance program.
The mean interval between renal transplantation and tumor development was 4.8 years in our study. The risk was highest in the first year after renal transplantation, both in men and women (SIRs 27.50 for men and 47.70 for women) and declined with increasing follow-up time. It is unclear why the risk is particularly high during the first several years after renal transplantation. It probably resulted from increased medical surveillance when being evaluated for transplantation or in the first several years after transplantation. The finding of a gradual reduction of cancer risk with increased post-transplantation follow-up time in our RTRs implied that cancer risk is not completely explained by cumulative influence of immunosuppressants. Furthermore, the relatively short follow-up time,~10 years, in the present study may have led to underestimation of late-onset post-transplantation malignancies. The precise patterns of posttransplant malignancies over time are somewhat uncertain. One study reported the highest SIRs occurring among RTRs after 10 years post-transplantation [3] , whereas some studies demonstrated a reduction in risk over time [6] [7] [8] . Further studies to clarify this issue are needed. The strengths of our study included the large number of cases, the high validity of the cancer diagnoses based on cytological and pathological evidence and the utilization of SIRs to compare the risk of cancer development in Asian RTRs with that expected in the age-matched general population. Nonetheless, there were some limitations in this study. First, cancer incidence rate can be mildly underestimated because it is not mandatory but rather voluntary to apply for a catastrophic illness certificate. This influence was trivial because the patients applying for a catastrophic illness certificate are granted exemption from co-payment related to the same catastrophic illness in Taiwan. Second, risk factors of cancers such as lifestyle, smoking and alcohol use, ultraviolet exposure, skin type and family history of malignancy were not recorded in the database. Moreover, relatively short duration of follow-up may affect the accuracy of estimates of late-onset post-transplantation malignancies. It is important to continue this study to evaluate the risk of post-transplantation malignancies in the long-term follow-up of RTRs.
In conclusion, we confirmed that the incidence of malignancy in RTRs is markedly greater than that in the general population. The types of post-transplantation malignancies among RTRs in our study differed from those among RTRs from Western countries. The results emphasize the need for vigilant surveillance of malignancy after transplant given the findings of a variety of malignancies, which could help conduct a cost-effective post-renal transplantation cancer surveillance program. Our data showed that the most common cancers in Asian RTRs were kidney and bladder cancers. A vigorous screening for a kidney and bladder cancer may be mandatory not only post-transplant but also in the pre-transplant setting. Younger recipients need a more intensive cancer surveillance program.
